See how top analysts and institutions rate TSLA — including buy, hold, and sell recommendations.
| Rating Source | Action | Rating | Target Price | Updated |
|---|---|---|---|---|
| BNP Paribas Exane | Initiated | Underperform | $307 | 2025-10-16 |
| Barclays | Reiterated | Equal Weight | $275 → $350 | 2025-10-16 |
| Melius | Initiated | Buy | $520 | 2025-10-13 |
| RBC Capital Mkts | Reiterated | Outperform | $325 → $500 | 2025-10-10 |
| TD Cowen | Reiterated | Buy | $374 → $509 | 2025-10-09 |
| Stifel | Reiterated | Buy | $440 → $483 | 2025-10-08 |
| Canaccord Genuity | Reiterated | Buy | $333 → $490 | 2025-09-30 |
| Deutsche Bank | Reiterated | Buy | $345 → $435 | 2025-09-26 |
| Mizuho | Reiterated | Outperform | $375 → $450 | 2025-09-23 |
| Piper Sandler | Reiterated | Overweight | $400 → $500 | 2025-09-22 |
| Robert W. Baird | Upgrade | Neutral → Outperform | $548 | 2025-09-19 |
| Goldman | Reiterated | Neutral | $300 → $395 | 2025-09-18 |
| RBC Capital Mkts | Reiterated | Outperform | $319 → $325 | 2025-07-29 |
| China Renaissance | Downgrade | Buy → Hold | $349 | 2025-07-25 |
| Canaccord Genuity | Reiterated | Buy | $303 → $333 | 2025-07-24 |
| William Blair | Downgrade | Outperform → Mkt Perform | 2025-07-07 | |
| The Benchmark Company | Reiterated | Buy | $350 → $475 | 2025-06-26 |
| Argus | Downgrade | Buy → Hold | 2025-06-09 | |
| Robert W. Baird | Downgrade | Outperform → Neutral | $320 | 2025-06-09 |
| Date | Strong Buy | Buy | Hold | Sell | Strong Sell |
|---|---|---|---|---|---|
| November 2025 | 5 | 15 | 17 | 7 | 3 |
| October 2025 | 5 | 15 | 17 | 7 | 3 |
| September 2025 | 5 | 15 | 17 | 6 | 2 |
| August 2025 | 5 | 14 | 18 | 7 | 3 |
The majority of institutional investors have issued a "Buy" rating for TSLA, and analyst sentiment aligns closely, with very few "Sell" recommendations. This suggests a broadly favorable outlook for the stock's performance.
